High levels of adherence to study medication among women who conceived during HIV PrEP study
PrEP users say it provides an 'extra layer of protection' and 'peace of mind'
People starting therapy on a boosted protease inhibitor don't need to switch after one virological failure episode, study indicates
Daily dosing key to the efficacy of tenofovir-based HIV PrEP
New booklet from NAM: Taking your HIV treatment